Moral Hazard and Long-Term Care Insurance
道德风险和长期护理保险
基本信息
- 批准号:8332824
- 负责人:
- 金额:$ 26.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-15 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdultAgeAreaAttentionBehaviorBeliefBudgetsCommunitiesDataDisability InsuranceElderlyGovernmentHealthHealth InsuranceHealthcareHome Care ServicesHome Nursing CareHome environmentIncomeIndividualInferiorInsuranceInsurance CarriersInsurance CoverageLiteratureLong-Term CareLong-Term Care InsuranceMarketingMedicaidMethodsMinorityMoralsNatureNursing HomesPoliciesPolicy DevelopmentsPopulationPricePublic PolicyRelative (related person)ResearchResearch PersonnelRetirementRunningServicesSocial WelfareSolutionsSystemWorkbasecommunity based servicecommunity livingconsumer behaviorcostdemographicsdesignevidence baseexhausthazardimprovedpatient home careservice utilizationsimulation
项目摘要
Project Summary
Recent passage of the Community Living Assistance Services and Supports (CLASS) Act as part of
health reform has drawn renewed attention to the long-term care insurance market, a market which has long
presented many unanswered questions to researchers and policymakers. Despite the potentially high cost of
long-term care and the skewed distribution of those costs, only 10% of elderly adults have long-term care
insurance, and insurers consequently express greater concern about adverse selection and moral hazard than
in typical health insurance markets. While a limited body of research has begun to make progress in
understanding long-term care insurance markets and associated behavior, the extent of adverse selection and
moral hazard remain largely unknown. Regardless of the eventual fate or form of CLASS, the projected
demographics of long-term care use and the associated strain on government budgets point to a more and
more urgent need to answer these questions. A particularly under-researched area is that of moral hazard, or
the additional use of services that can be attributed to long-term care insurance coverage. Existing research
finds little evidence for moral hazard in the case of Medicaid-financed nursing home use, but Medicaid-
financed nursing home use may be considered an inferior good. Home health care and privately financed
nursing home use may be normal goods and thus more likely to be subject to moral hazard. A broader
perspective, including all nursing home use and especially favorable alternatives to nursing homes, such as
home care, is required in order to capture fully the extent of moral hazard. Furthermore, recent theoretical
work has revisited the common assumption that all moral hazard is welfare-reducing, positing instead that
moral hazard attributable to income effects is efficient and welfare-improving while moral hazard attributable to
price effects remains inefficient and welfare-reducing. This distinction may be particularly important in long-
term care, an area of health care in which public payers currently dominate. In this project, we propose to use
a long panel of the Health and Retirement Study to 1) assess the overall extent of moral hazard associated
with long-term care insurance coverage, including use of home care; 2) disentangle the estimated moral
hazard into efficient moral hazard due to the income effect and inefficient moral hazard due to the price effect,
thereby enabling an assessment of the net welfare effect; and 3) conduct policy simulations to aid in
appropriate benefit design. Assessing the extent of moral hazard associated with long-term care insurance
coverage is essential to financial viability and sustainability of the market, to appropriate benefit design, and to
an assessment of the overall welfare effects of a public policy such as CLASS.
项目摘要
最近通过的《社区生活援助服务和支助法》,
医疗改革重新引起了人们对长期护理保险市场的关注,
给研究人员和政策制定者提出了许多未解之谜。尽管潜在的高成本,
长期护理和这些费用的倾斜分布,只有10%的老年人有长期护理
因此,保险公司对逆向选择和道德风险的关注比
典型的健康保险市场。虽然有限的研究机构已经开始取得进展,
了解长期护理保险市场和相关行为,逆向选择的程度,
道德风险在很大程度上仍不为人所知。不管CLASS的最终命运或形式如何,
长期护理使用的人口统计数据和政府预算的相关压力表明,
更迫切需要回答这些问题。一个特别缺乏研究的领域是道德风险,或
额外使用可归因于长期护理保险的服务。现有研究
在医疗补助资助的疗养院使用的情况下,几乎没有发现道德风险的证据,但医疗补助-
受资助的疗养院使用可被认为是次优品。家庭保健和私人融资
疗养院的使用可能是正常的商品,因此更有可能受到道德风险的影响。更广泛的
观点,包括所有疗养院的使用和特别有利的替代疗养院,如
为了充分掌握道德风险的程度,需要进行家庭护理。此外,最近的理论
工作已经重新审视了共同的假设,所有的道德风险是减少福利,而不是假设,
道德风险归因于收入效应是有效率的和福利改善,而道德风险归因于
价格效应仍然是低效和减少福利的。这种区别在长期内可能特别重要-
长期护理,目前公共支付者占主导地位的卫生保健领域。在这个项目中,我们建议使用
健康与退休研究的一个长小组,以1)评估与健康相关的道德风险的总体程度,
长期护理保险覆盖范围,包括使用家庭护理; 2)解开估计的道德
道德风险分为收入效应引起的有效道德风险和价格效应引起的无效道德风险,
从而能够评估净福利效应; 3)进行政策模拟,以帮助
适当的福利设计。评估与长期护理保险相关的道德风险程度
覆盖面对于市场的财务可行性和可持续性、适当的福利设计以及
对一项公共政策(如CLASS)的总体福利影响的评估。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RITA TAMARA KONETZKA其他文献
RITA TAMARA KONETZKA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RITA TAMARA KONETZKA', 18)}}的其他基金
The Role of Medicaid HCBS in the Post-Acute Period
医疗补助 HCBS 在急性期后的作用
- 批准号:
10095390 - 财政年份:2020
- 资助金额:
$ 26.3万 - 项目类别:
Effects of Care Setting on Persons with Alzheimer's Disease and their Spouses
护理环境对阿尔茨海默病患者及其配偶的影响
- 批准号:
9383443 - 财政年份:2017
- 资助金额:
$ 26.3万 - 项目类别:
Patient Safety in Nursing Homes: A Closer Look at Improvement
疗养院患者安全:仔细观察改进
- 批准号:
9348621 - 财政年份:2016
- 资助金额:
$ 26.3万 - 项目类别:
Patient Safety in Nursing Homes: A Closer Look at Improvement
疗养院患者安全:仔细观察改进
- 批准号:
9219412 - 财政年份:2016
- 资助金额:
$ 26.3万 - 项目类别:
Improving Nursing Home Compare for Dually Eligible Consumers
改善具有双重资格的消费者的疗养院比较
- 批准号:
8450495 - 财政年份:2012
- 资助金额:
$ 26.3万 - 项目类别:
Improving Nursing Home Compare for Dually Eligible Consumers
改善具有双重资格的消费者的疗养院比较
- 批准号:
8723055 - 财政年份:2012
- 资助金额:
$ 26.3万 - 项目类别:
Improving Nursing Home Compare for Dually Eligible Consumers
改善具有双重资格的消费者的疗养院比较
- 批准号:
8550793 - 财政年份:2012
- 资助金额:
$ 26.3万 - 项目类别:
Profitability and Public Reporting: Evidence from Nursing Homes
盈利能力和公共报告:来自疗养院的证据
- 批准号:
8330801 - 财政年份:2011
- 资助金额:
$ 26.3万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 26.3万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 26.3万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 26.3万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 26.3万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 26.3万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 26.3万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 26.3万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 26.3万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 26.3万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 26.3万 - 项目类别:
Research Grant